The prevalence of obesity is increasing worldwide and with it the health risks that are associated with this condition. Rhett Women’s Center helps women drop unwanted and unhealthy weight with a myriad of effective treatments ranging from appetite suppressants, supplements, Semaglutide prescriptions and management, and vitamin B-12 injections. The mainstay of obesity treatment is lifestyle change, including diet and physical activity. However, for many women seeking to lose weight, diet and lifestyle changes are not enough.

For the first time in over a decade, a new weight loss drug shows proven results. Semaglutide is a new medication that has evidence-based results in clinical trial studies. These recent studies aim to evaluate the efficacy of Semaglutide for weight loss in women.

What is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is a drug that has been approved by the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes, but it has also been studied for its potential role in weight loss.

Semaglutide, which is administered by injection, works by mimicking the actions of the hormones GLP-1, GIP, and glucagon, which are involved in appetite regulation and regulating insulin production. In clinical studies, Semaglutide has been shown to reduce hunger and help promote weight loss without causing adverse side effects.

What was the aim of the Semaglutide Women’s Weight Loss study?

The primary aim of this study was to investigate the safety and efficacy of Semaglutide as an adjunct to diet and lifestyle modification for weight maintenance in overweight and obese women. The study participants were required to stay on their individual medical and lifestyle interventions throughout the length of the study.

The investigators also assessed how well Semaglutide performed on other outcomes, including:

1. waist circumference
2. fat mass
3. its effects on hunger and appetite ratings
4. changes in glycemic control
5. blood pressure and cholesterol levels

What were the results of the study?

At the end of the study, women between the ages of 18 and 70 with ranging body mass taking Semaglutide showed a statistically significant reduction in body weight compared to those taking the placebo. Participants taking Semaglutide also showed a statistically significant reduction in body fat and waist circumference compared to the placebo group.

In addition, the study showed that Semaglutide significantly improved other metabolic health indicators in women including fasting blood glucose, insulin levels, total cholesterol, HDL cholesterol, triglycerides, hepatic transaminase levels, and C-reactive protein levels.

Overall, the results of the study indicate that Semaglutide was effective in helping overweight and obese women to lose weight and improve their metabolic health.

What are the proven benefits of Semaglutide for women’s weight loss?

1. Semaglutide is effective in helping overweight and obese women to lose and maintain weight.
2. Semaglutide aids in weight loss and metabolic health improvement by suppressing appetite and inducing satiety, in addition to influencing other pathways regulating appetite, food intake, and metabolism.
3. The drug safely induces weight loss without causing severe side effects.
4. The drug may offer long-term benefits for energy balance, glycemic control and other metabolic parameters.

Rhett Women’s Center providers are effectively using Semaglutide to significantly reduce weight and body mass index, with improvements in physical fitness, waist circumference and metabolic biomarkers, in women patients. Call or request an appointment online to see if you are a candidate for this well-tolerated weight loss, breakthrough drug.